Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03125343 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Watch and Wait as Treatment for Patients With Rectal Cancer

Study acronym: WoW
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 7, 2023 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 200 to 400
    • Primary completion date: Apr 2023 to Dec 2025
    • Study completion date: Apr 2024 to Dec 2028
    • Study description expanded, about 43 words
    v7
  2. Re-verified, no change to tracked fieldsv6
  3. Primary completion date: Apr 2021 to Apr 2023v5
  4. 2 versions Re-verified since Sep 17, 2019, no change to tracked fieldsv3-v4
  5. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 2 of 2 sites
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A national cohort study with all patients scheduled for neoadjuvant treatment with (chemo)radiotherapy or short course radiotherapy with delayed surgery 6-8 weeks) for rectal cancer staged as cT4bNX/anycTanycN and cMRF+/anycTanycN and lateral lymph nodes on MRI (and patients that have been offered short course raditotherapy with delayed surgery due to various reasons). The tumours are positioned midrectal or low and are palpable with the finger. The patients offered this treatment after recommendations on their local multidisciplinary tumour board will be will be informed and offered to participate in the study. Patients scheduled for short course radiotherapy with immediate surgery cannot be included.
Trial Details
NCT Number NCT03125343
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Karolinska Institutet
Conditions
(from sponsor)		 Rectal Neoplasms
Related terms Pathologic Complete Response, Rectal Neoplasms
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov